Individualized Antiplatelet Therapy After Drug-Eluting Stent Deployment: Implication of Clinical Trials of Different Durations of Dual Antiplatelet Therapy

Journal of Cardiology - Japan
doi 10.1016/j.jjcc.2017.06.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Antiplatelet Therapy After Drug-Eluting Stent Implantation

Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

Antiplatelet Therapy Following Stent Deployment

Heart
Cardiovascular MedicineCardiology
1997English

Very Late Drug-Eluting Stent Thrombosis After Nonsteroidal Anti-Inflammatory Drug Treatment Despite Dual Antiplatelet Therapy

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2009English

Dual Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation in China: A Large Single Center Study

Catheterization and Cardiovascular Interventions
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2018English

Three-Month Dual Antiplatelet Therapy After Implantation of Zotarolimus-Eluting Stents

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Efficacy and Safety of 12 Versus 48 Months of Dual Antiplatelet Therapy After Implantation of a Drug-Eluting Stent: The OPTImal DUAL Antiplatelet Therapy (OPTIDUAL) Trial: Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2013English

Short- Versus Long-Term Dual Antiplatelet Therapy After Second-Generation Drug-Eluting Stent Implantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Should Dual Antiplatelet Therapy After Drug-Eluting Stents Be Continued for More Than 1 Year?: Dual Antiplatelet Therapy After Drug-Eluting Stents Should Be Continued for More Than One Year and Preferably Indefinitely

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2008English

Addition of Cilostazol to Conventional Dual Antiplatelet Therapy Reducing the Risk of Cardiac Events and Restenosis After Drug-Eluting Stent Implantation: A Meta-Analysis

Heart
Cardiovascular MedicineCardiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy